Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Transplant Proc ; 50(3): 857-860, 2018 Apr.
Article in English | MEDLINE | ID: mdl-29661453

ABSTRACT

Post-transplantation lymphoproliferative disorder (PTLD) is a heterogeneous group of conditions that complicate organ transplantation and are due to immunosuppression. Central nervous system (CNS)-PTLD is rare but its incidence is increasing. It often occurs late and is associated with kidney transplantation and Epstein-Barr virus (EBV) infection. Outcomes are poor. We present the case of a 77-year-old white male who received a cadaveric kidney transplant in 2003. Maintenance immunosuppression consisted of mycofenolate mofetil (MMF), cyclosporine, and prednisolone. In 2017, while admitted for other cause, he presented with de novo epileptic seizures. Because the patient had a pacemaker, magnetic resonance imaging (MRI) could not be performed. The final diagnosis of CNS-PTLD was known through brain biopsy, after a suitable image was obtained with contrasted brain computed tomography (CT). EBV was positive in brain biopsy, cefalospinal fluid, and blood. Treatment was attempted with reduction of immunosuppression. Cyclosporine was switched to sirolimus. The patient died before administration of rituximab. The patient's performance status was poor. There must be awareness for neurological symptoms after kidney transplantation to timely diagnose CNS-PTLD. Contrasted brain CT may be useful to obtain a biopsy specimen in cases where MRI is impossible to use.


Subject(s)
Central Nervous System Diseases/virology , Epstein-Barr Virus Infections/complications , Kidney Transplantation/adverse effects , Lymphoproliferative Disorders/virology , Postoperative Complications/virology , Aged , Biopsy , Brain/pathology , Brain/virology , Fatal Outcome , Humans , Immunosuppression Therapy/adverse effects , Immunosuppression Therapy/methods , Kidney/virology , Male
2.
Andrologia ; 50(1)2018 Feb.
Article in English | MEDLINE | ID: mdl-28730698

ABSTRACT

This study evaluated effects of diet supplementation with omega-3 polyunsaturated fatty acids (PUFA) from microalgae on boar sperm quality. Two groups of boars (n = 3 each) were fed during 75 days either a commercial diet (control), or the same diet supplemented with omega-3 PUFA from the heterotrophic microalgae Schizochytrium sp. (120 g/kg). Sixteen ejaculates were collected per boar. Some sperm kinetics parameters were inferior for supplemented than for control boars (p < .05): distance average path; distance in both curved and straight line; velocity average path, velocity in both curved and straight line; and amplitude of lateral head displacement. Spermatozoa from supplemented boars presented lower mitochondrial functionality, but greater membrane fluidity compared to the control group (p < .01). Membrane and acrosome integrity, production of reactive oxygen species and lipid peroxidation did not differ (p > .05). Serum cholesterol levels were greater (p < .05) for supplemented than for control boars at the 30th and 60th d of supplementation, but levels of triglycerides and IGF-1 did not differ (p > .05). Compared to the control, spermatozoa of supplemented boars were slower, travelled shorter distances and presented impaired energy metabolism, but their greater membrane fluidity may potentially favour their cryopreservation.


Subject(s)
Diet/veterinary , Dietary Supplements , Fatty Acids, Omega-3/administration & dosage , Sperm Motility/drug effects , Spermatozoa/drug effects , Acrosome/drug effects , Acrosome/metabolism , Animals , Cell Membrane/drug effects , Cell Membrane/metabolism , Lipid Peroxidation/drug effects , Lipid Peroxidation/physiology , Male , Microalgae , Oxidative Stress/drug effects , Oxidative Stress/physiology , Reactive Oxygen Species/metabolism , Semen Analysis , Spermatozoa/cytology , Spermatozoa/metabolism , Swine
SELECTION OF CITATIONS
SEARCH DETAIL
...